Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
56 hedge funds and large institutions have $4.55M invested in Ampio Pharmaceuticals Inc. in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 17 closing their positions.
69% more call options, than puts
Call options by funds: $61K | Put options by funds: $36K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less funds holding
Funds holding: 64 → 56 (-8)
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
50% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 18
54% less capital invested
Capital invested by funds: $9.82M → $4.55M (-$5.27M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$311K |
| 2 |
Legal & General Group
London,
United Kingdom
|
+$216K |
| 3 |
ECM
Element Capital Management
New York
|
+$196K |
| 4 |
Goldman Sachs
New York
|
+$177K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$122K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.4M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$458K |
| 3 |
State Street
Boston,
Massachusetts
|
-$423K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$270K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$254K |
AMPE Hedge Fund Activity: Q2 2017 in Review
56 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2017, worth a combined $4.55M — down 54% from $9.82M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of AMPE and 10 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 9 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $311K. The largest seller was BlackRock, cutting an estimated $1.4M.
- 56 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2017, down from 64 in Q1 2017.
- Funds reported $4.55M of Ampio Pharmaceuticals Inc. stock for Q2 2017, down 54% quarter-over-quarter.
- 10 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2017 and 17 closed out, a net change of -7 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q2 2017 was Millennium Management, an estimated $311K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q2 2017 was BlackRock, an estimated $1.4M sold.
Based on aggregated 13F filings for Q2 2017.